Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. In 2020 it had a revenue of SEK 15,261million and 1,509 employees.

Revenue(RF), mln.USD
8
Assets(RF), mln.USD
2
Capital(RF), mln.USD
1
Staff(RF), 2021
27
The Company Statement

Received revenues in Russia in 2021, there is no any official announcement

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner